GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Covalon Technologies Ltd (TSXV:COV) » Definitions » Shiller PE Ratio

Covalon Technologies (TSXV:COV) Shiller PE Ratio : (As of Jun. 04, 2024)


View and export this data going back to 2004. Start your Free Trial

What is Covalon Technologies Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Covalon Technologies Shiller PE Ratio Historical Data

The historical data trend for Covalon Technologies's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Covalon Technologies Shiller PE Ratio Chart

Covalon Technologies Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Covalon Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Covalon Technologies's Shiller PE Ratio

For the Biotechnology subindustry, Covalon Technologies's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Covalon Technologies's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Covalon Technologies's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Covalon Technologies's Shiller PE Ratio falls into.



Covalon Technologies Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Covalon Technologies's E10 for the quarter that ended in Mar. 2024 is calculated as:

For example, Covalon Technologies's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0.06/126.2576*126.2576
=0.060

Current CPI (Mar. 2024) = 126.2576.

Covalon Technologies Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201406 -0.030 99.473 -0.038
201409 -0.100 99.394 -0.127
201412 -0.020 98.367 -0.026
201503 0.010 99.789 0.013
201506 -0.010 100.500 -0.013
201509 -0.090 100.421 -0.113
201512 0.020 99.947 0.025
201603 -0.100 101.054 -0.125
201606 -0.020 102.002 -0.025
201609 -0.170 101.765 -0.211
201612 0.030 101.449 0.037
201703 0.020 102.634 0.025
201706 0.020 103.029 0.025
201709 0.020 103.345 0.024
201712 0.020 103.345 0.024
201803 -0.020 105.004 -0.024
201806 0.090 105.557 0.108
201809 -0.030 105.636 -0.036
201812 -0.090 105.399 -0.108
201903 -0.010 106.979 -0.012
201906 -0.160 107.690 -0.188
201909 -0.160 107.611 -0.188
201912 -0.050 107.769 -0.059
202003 -0.150 107.927 -0.175
202006 0.010 108.401 0.012
202009 -0.090 108.164 -0.105
202012 -0.010 108.559 -0.012
202103 0.010 110.298 0.011
202106 0.040 111.720 0.045
202109 0.870 112.905 0.973
202112 -0.060 113.774 -0.067
202203 -0.090 117.646 -0.097
202206 -0.060 120.806 -0.063
202209 -0.160 120.648 -0.167
202212 -0.020 120.964 -0.021
202303 -0.030 122.702 -0.031
202306 -0.020 124.203 -0.020
202309 -0.120 125.230 -0.121
202312 -0.030 125.072 -0.030
202403 0.060 126.258 0.060

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Covalon Technologies  (TSXV:COV) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Covalon Technologies Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Covalon Technologies's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Covalon Technologies (TSXV:COV) Business Description

Traded in Other Exchanges
Address
1660 Tech Avenue, Unit 5, Mississauga, ON, CAN, L4W 5S7
Covalon Technologies Ltd is principally engaged in the business of developing, licensing, and selling medical technologies. The company develops advanced wound care line which is designed for the treatment of a wide range of wounds; and infection prevention products such as MediClear PreOp which is a breathable, transparent, self-adhesive silicone barrier film that conforms to the contours of the body. It also develops perioperative care products. The company generates its revenue through development contracts, licensing agreements, and distribution contracts, and sales.
Executives
Valerio Ditizio Director or Senior Officer of 10% Security Holder, Senior Officer

Covalon Technologies (TSXV:COV) Headlines

No Headlines